GPC3-targeted CAR-M cells exhibit potent antitumor activity against hepatocellular carcinoma
{{output}}
Chimeric antigen receptor (CAR)-modified macrophages are a promising treatment for solid tumor. So far the potential effects of CAR-M cell therapy have rarely been investigated in hepatocellular carcinoma (HCC). Glypican-3 (GPC3) is a biomarker for a variety o... ...
